Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Carr (Mission Viejo, United States of America), D. Jackson (London, United Kingdom), J. Corren (Los Angeles, United States of America), K. Bergmann (Berlin, Germany), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America). Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline. 536

Member's Comments

No comment yet.

Related content which might interest you: Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 CD6-ALCAM Pathway is Elevated in Patients with Severe Asthma Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Long-Term Remission and Changes in the Severity of Asthma over 30 Years–  TRAIL Cohort Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study. Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Problems of Importance in Severe Asthma: A Patient Perspective Source: International Congress 2019 – Person-centred approaches to COPD and asthma care Year: 2019